Lipocalin-type prostaglandin D 2 synthase (L-PGDS) modulates beneficial metabolic effects of vertical sleeve gastrectomy

• Published in: Surgery for obesity and related diseases Vol. 12; no. 8; p. 1523
• Main Authors: Kumar, Sunil, Lau, Raymond, Hall, Christopher E, Palaia, Thomas, Rideout, Drew A, Brathwaite, Collin E, Ragolia, Louis
• Format: Journal Article
• Language: English
• Published: United States 01.09.2016
• Subjects: Adipocytes - pathology; Analysis of Variance; Animals; Bariatric Surgery - methods; Blood Glucose - metabolism; Cholesterol - metabolism; Diet, High-Fat; Fasting - blood; Gastrectomy - methods; Glucose Intolerance - enzymology; Glucose Intolerance - pathology; Glucose Intolerance - surgery; Homeostasis; Insulin Resistance - physiology; Intramolecular Oxidoreductases - physiology; Leptin - metabolism; Lipocalins - physiology; Male; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Obesity - enzymology; Obesity - pathology; Obesity - surgery; Weight Loss; Glucose tolerance; Vertical sleeve gastrectomy; L-PGDS knock-in; L-PGDS knockout
• ISSN: 1878-7533

Vertical sleeve gastrectomy (VSG) ameliorates metabolic complications in obese and diabetic patients through unknown mechanisms. The objective of this study was to investigate the role of lipocalin-type prostaglandin D synthase (L-PGDS) in glucose regulation in response to VSG using L-PGDS knock-out (KO), knock-in (KI), and C57BL/6 (wild type) mice. Winthrop University Hospital Research Institute. Animals were divided into 6 groups: L-PGDS KO sham/VSG (n = 5), L-PGDS KI sham/VSG (n = 5), and C57BL/6 (wild type) sham/VSG (n = 5). Related parameters were measured in fasting animals after 10 weeks. Our intraperitoneal glucose tolerance tests and homeostatic model assessment insulin resistance results showed significant glycemic improvement 10 weeks post-VSG in both C57BL/6 and KI groups compared with the sham group. In contrast, the KO group developed glucose intolerance and insulin resistance similar to or greater than the sham group 10 weeks post-VSG. Interestingly, weight gain was insignificant 10 weeks post-VSG in all the groups and even trended higher in the KO group compared with sham. Peptide YY levels in the KO group post-VSG were slightly increased but significantly less than other groups. Similarly, the KO group showed significantly less leptin sensitivity in response to VSG compared with the KI group. Total cholesterol level remained unchanged in all groups irrespective of sham or surgery but interestingly, the KO group had significantly higher cholesterol levels. In parallel, adipocyte size was also found to be significantly increased in the KO group post-VSG compared with the sham group. Our findings propose that L-PGDS plays an important role in the beneficial metabolic effects observed after VSG.